Discover how Molecular Allergy Diagnosis (MAD) and the advanced ALEX2 multiplex system are transforming the way healthcare professionals identify and treat seasonal allergies. New research reveals how MAD overcomes the limitations of traditional testing by eliminating cross-reactivity and delivering highly accurate, patient-specific results. Explore why this next-generation approach is redefining allergy diagnosis and improving outcomes for allergy sufferers.